Brief: Beam Therapeutics Reports Q4 Loss Of $0.54 Per Share

Beam Therapeutics

28/02/2023 11:43

Feb 28 (Reuters) - Beam Therapeutics Inc  BEAM.O :
    * BEAM THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2022
FINANCIAL RESULTS AND REITERATES ANTICIPATED MILESTONES
    * Q4 LOSS PER SHARE $0.54
    * Q4 EARNINGS PER SHARE VIEW $-1.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2CzvcF 
Further company coverage:  BEAM.O 

 ((Reuters.Briefs@thomsonreuters.com;))